Characteristics and Treatment Outcomes of Benign Paroxysmal Positional Vertigo in a Cohort of Veterans.
Identifieur interne : 000114 ( Main/Exploration ); précédent : 000113; suivant : 000115Characteristics and Treatment Outcomes of Benign Paroxysmal Positional Vertigo in a Cohort of Veterans.
Auteurs : Faith W. Akin [États-Unis] ; Kristal M. Riska [États-Unis] ; Laura Williams [États-Unis] ; Stephanie B. Rouse [États-Unis] ; Owen D. Murnane [États-Unis]Source :
- American journal of audiology [ 1558-9137 ] ; 2017.
Descripteurs français
- KwdFr :
- Adulte (MeSH), Adulte d'âge moyen (MeSH), Anciens combattants (MeSH), Femelle (MeSH), Humains (MeSH), Mâle (MeSH), Positionnement du patient (méthodes), Protein-Serine-Threonine Kinases (MeSH), Protéines de Drosophila (MeSH), Prévalence (MeSH), Récidive (MeSH), Résultat thérapeutique (MeSH), Sujet âgé (MeSH), Sujet âgé de 80 ans ou plus (MeSH), Vertige positionnel paroxystique bénin (thérapie), Vertige positionnel paroxystique bénin (épidémiologie), États-Unis (épidémiologie), Études de cohortes (MeSH), Études rétrospectives (MeSH).
- MESH :
- méthodes : Positionnement du patient.
- thérapie : Vertige positionnel paroxystique bénin.
- épidémiologie : Vertige positionnel paroxystique bénin, États-Unis.
- Adulte, Adulte d'âge moyen, Anciens combattants, Femelle, Humains, Mâle, Protein-Serine-Threonine Kinases, Protéines de Drosophila, Prévalence, Récidive, Résultat thérapeutique, Sujet âgé, Sujet âgé de 80 ans ou plus, Études de cohortes, Études rétrospectives.
English descriptors
- KwdEn :
- Adult (MeSH), Aged (MeSH), Aged, 80 and over (MeSH), Benign Paroxysmal Positional Vertigo (epidemiology), Benign Paroxysmal Positional Vertigo (therapy), Cohort Studies (MeSH), Drosophila Proteins (MeSH), Female (MeSH), Humans (MeSH), Male (MeSH), Middle Aged (MeSH), Patient Positioning (methods), Prevalence (MeSH), Protein-Serine-Threonine Kinases (MeSH), Recurrence (MeSH), Retrospective Studies (MeSH), Treatment Outcome (MeSH), United States (epidemiology), Veterans (MeSH).
- MESH :
- chemical : Drosophila Proteins, Protein-Serine-Threonine Kinases.
- epidemiology : Benign Paroxysmal Positional Vertigo, United States.
- methods : Patient Positioning.
- therapy : Benign Paroxysmal Positional Vertigo.
- Adult, Aged, Aged, 80 and over, Cohort Studies, Female, Humans, Male, Middle Aged, Prevalence, Recurrence, Retrospective Studies, Treatment Outcome, Veterans.
Abstract
Background
The Mountain Home Veterans Affairs (VA) Medical Center has been diagnosing and treating veterans with benign paroxysmal positional vertigo (BPPV) for almost 2 decades. The clinic protocol includes a 2-week follow-up visit to determine the treatment outcome of the canalith repositioning treatment (CRT). To date, the characteristics of BPPV and treatment efficacy have not been reported in a cohort of veterans with BPPV.
Purpose
To determine the prevalence and characteristics of veterans diagnosed with BPPV in a Veterans Affairs Medical Center Audiology Clinic and to examine treatment outcomes.
Research Design
Retrospective chart review.
Study Sample
A total of 102 veterans who tested positive for BPPV in the Vestibular Clinic at the Mountain Home VA Medical Center from March 2010 to August 2011.
Results
In 102 veterans who were diagnosed with BPPV, the posterior semicircular canal was most often involved (75%), motion-provoked vertigo was the most common symptom (84%), and the majority (43%) were diagnosed with BPPV in their sixth decade. The prevalence of BPPV in the Audiology Vestibular Clinic was 15.6%. Forty-one percent of veterans reported a symptom onset within 12 months of treatment for BPPV; however, 36% reported their symptoms began > 36 months prior to treatment. CRT was effective (negative Dix-Hallpike/roll test) in most veterans (86%) following 1 treatment appointment (M = 1.6), but more than half reported incomplete symptom resolution (residual dizziness) at the follow-up appointment. Eighteen percent of veterans experienced a recurrence (M = 1.8 years; SD = 1.7 years).
Conclusions
The characteristics and treatment outcomes of BPPV in our veteran cohort was similar to what has been reported in the general population. Future work should focus on improving the timeliness of evaluation and treatment of BPPV and examining the time course and management of residual dizziness.
DOI: 10.1044/2017_AJA-16-0118
PubMed: 28973090
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Characteristics and Treatment Outcomes of Benign Paroxysmal Positional Vertigo in a Cohort of Veterans.</title><author><name sortKey="Akin, Faith W" sort="Akin, Faith W" uniqKey="Akin F" first="Faith W" last="Akin">Faith W. Akin</name><affiliation wicri:level="2"><nlm:affiliation>Vestibular Balance Laboratory and Auditory Vestibular Research Enhancement Award Program, James H. Quillen VA Veterans Affairs Medical Center, Mountain Home, TN.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Tennessee</region></placeName><wicri:cityArea>Vestibular Balance Laboratory and Auditory Vestibular Research Enhancement Award Program, James H. Quillen VA Veterans Affairs Medical Center, Mountain Home</wicri:cityArea></affiliation><affiliation><nlm:affiliation>Department of Audiology and Speech-Language Pathology, East Tennessee State University, Johnson City.</nlm:affiliation><wicri:noCountry code="subField">Johnson City</wicri:noCountry></affiliation></author><author><name sortKey="Riska, Kristal M" sort="Riska, Kristal M" uniqKey="Riska K" first="Kristal M" last="Riska">Kristal M. Riska</name><affiliation wicri:level="2"><nlm:affiliation>Vestibular Balance Laboratory and Auditory Vestibular Research Enhancement Award Program, James H. Quillen VA Veterans Affairs Medical Center, Mountain Home, TN.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Tennessee</region></placeName><wicri:cityArea>Vestibular Balance Laboratory and Auditory Vestibular Research Enhancement Award Program, James H. Quillen VA Veterans Affairs Medical Center, Mountain Home</wicri:cityArea></affiliation><affiliation><nlm:affiliation>Department of Audiology and Speech-Language Pathology, East Tennessee State University, Johnson City.</nlm:affiliation><wicri:noCountry code="subField">Johnson City</wicri:noCountry></affiliation></author><author><name sortKey="Williams, Laura" sort="Williams, Laura" uniqKey="Williams L" first="Laura" last="Williams">Laura Williams</name><affiliation><nlm:affiliation>Department of Audiology and Speech-Language Pathology, East Tennessee State University, Johnson City.</nlm:affiliation><wicri:noCountry code="subField">Johnson City</wicri:noCountry></affiliation><affiliation wicri:level="2"><nlm:affiliation>Audiology and Speech Pathology Service, San Diego VA Medical Center, La Jolla, CA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Audiology and Speech Pathology Service, San Diego VA Medical Center, La Jolla</wicri:cityArea></affiliation></author><author><name sortKey="Rouse, Stephanie B" sort="Rouse, Stephanie B" uniqKey="Rouse S" first="Stephanie B" last="Rouse">Stephanie B. Rouse</name><affiliation wicri:level="2"><nlm:affiliation>Vestibular Balance Laboratory and Auditory Vestibular Research Enhancement Award Program, James H. Quillen VA Veterans Affairs Medical Center, Mountain Home, TN.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Tennessee</region></placeName><wicri:cityArea>Vestibular Balance Laboratory and Auditory Vestibular Research Enhancement Award Program, James H. Quillen VA Veterans Affairs Medical Center, Mountain Home</wicri:cityArea></affiliation></author><author><name sortKey="Murnane, Owen D" sort="Murnane, Owen D" uniqKey="Murnane O" first="Owen D" last="Murnane">Owen D. Murnane</name><affiliation wicri:level="2"><nlm:affiliation>Vestibular Balance Laboratory and Auditory Vestibular Research Enhancement Award Program, James H. Quillen VA Veterans Affairs Medical Center, Mountain Home, TN.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Tennessee</region></placeName><wicri:cityArea>Vestibular Balance Laboratory and Auditory Vestibular Research Enhancement Award Program, James H. Quillen VA Veterans Affairs Medical Center, Mountain Home</wicri:cityArea></affiliation><affiliation><nlm:affiliation>Department of Audiology and Speech-Language Pathology, East Tennessee State University, Johnson City.</nlm:affiliation><wicri:noCountry code="subField">Johnson City</wicri:noCountry></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28973090</idno><idno type="pmid">28973090</idno><idno type="doi">10.1044/2017_AJA-16-0118</idno><idno type="wicri:Area/Main/Corpus">000099</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000099</idno><idno type="wicri:Area/Main/Curation">000099</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000099</idno><idno type="wicri:Area/Main/Exploration">000099</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Characteristics and Treatment Outcomes of Benign Paroxysmal Positional Vertigo in a Cohort of Veterans.</title><author><name sortKey="Akin, Faith W" sort="Akin, Faith W" uniqKey="Akin F" first="Faith W" last="Akin">Faith W. Akin</name><affiliation wicri:level="2"><nlm:affiliation>Vestibular Balance Laboratory and Auditory Vestibular Research Enhancement Award Program, James H. Quillen VA Veterans Affairs Medical Center, Mountain Home, TN.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Tennessee</region></placeName><wicri:cityArea>Vestibular Balance Laboratory and Auditory Vestibular Research Enhancement Award Program, James H. Quillen VA Veterans Affairs Medical Center, Mountain Home</wicri:cityArea></affiliation><affiliation><nlm:affiliation>Department of Audiology and Speech-Language Pathology, East Tennessee State University, Johnson City.</nlm:affiliation><wicri:noCountry code="subField">Johnson City</wicri:noCountry></affiliation></author><author><name sortKey="Riska, Kristal M" sort="Riska, Kristal M" uniqKey="Riska K" first="Kristal M" last="Riska">Kristal M. Riska</name><affiliation wicri:level="2"><nlm:affiliation>Vestibular Balance Laboratory and Auditory Vestibular Research Enhancement Award Program, James H. Quillen VA Veterans Affairs Medical Center, Mountain Home, TN.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Tennessee</region></placeName><wicri:cityArea>Vestibular Balance Laboratory and Auditory Vestibular Research Enhancement Award Program, James H. Quillen VA Veterans Affairs Medical Center, Mountain Home</wicri:cityArea></affiliation><affiliation><nlm:affiliation>Department of Audiology and Speech-Language Pathology, East Tennessee State University, Johnson City.</nlm:affiliation><wicri:noCountry code="subField">Johnson City</wicri:noCountry></affiliation></author><author><name sortKey="Williams, Laura" sort="Williams, Laura" uniqKey="Williams L" first="Laura" last="Williams">Laura Williams</name><affiliation><nlm:affiliation>Department of Audiology and Speech-Language Pathology, East Tennessee State University, Johnson City.</nlm:affiliation><wicri:noCountry code="subField">Johnson City</wicri:noCountry></affiliation><affiliation wicri:level="2"><nlm:affiliation>Audiology and Speech Pathology Service, San Diego VA Medical Center, La Jolla, CA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Audiology and Speech Pathology Service, San Diego VA Medical Center, La Jolla</wicri:cityArea></affiliation></author><author><name sortKey="Rouse, Stephanie B" sort="Rouse, Stephanie B" uniqKey="Rouse S" first="Stephanie B" last="Rouse">Stephanie B. Rouse</name><affiliation wicri:level="2"><nlm:affiliation>Vestibular Balance Laboratory and Auditory Vestibular Research Enhancement Award Program, James H. Quillen VA Veterans Affairs Medical Center, Mountain Home, TN.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Tennessee</region></placeName><wicri:cityArea>Vestibular Balance Laboratory and Auditory Vestibular Research Enhancement Award Program, James H. Quillen VA Veterans Affairs Medical Center, Mountain Home</wicri:cityArea></affiliation></author><author><name sortKey="Murnane, Owen D" sort="Murnane, Owen D" uniqKey="Murnane O" first="Owen D" last="Murnane">Owen D. Murnane</name><affiliation wicri:level="2"><nlm:affiliation>Vestibular Balance Laboratory and Auditory Vestibular Research Enhancement Award Program, James H. Quillen VA Veterans Affairs Medical Center, Mountain Home, TN.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Tennessee</region></placeName><wicri:cityArea>Vestibular Balance Laboratory and Auditory Vestibular Research Enhancement Award Program, James H. Quillen VA Veterans Affairs Medical Center, Mountain Home</wicri:cityArea></affiliation><affiliation><nlm:affiliation>Department of Audiology and Speech-Language Pathology, East Tennessee State University, Johnson City.</nlm:affiliation><wicri:noCountry code="subField">Johnson City</wicri:noCountry></affiliation></author></analytic><series><title level="j">American journal of audiology</title><idno type="eISSN">1558-9137</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term><term>Aged (MeSH)</term><term>Aged, 80 and over (MeSH)</term><term>Benign Paroxysmal Positional Vertigo (epidemiology)</term><term>Benign Paroxysmal Positional Vertigo (therapy)</term><term>Cohort Studies (MeSH)</term><term>Drosophila Proteins (MeSH)</term><term>Female (MeSH)</term><term>Humans (MeSH)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Patient Positioning (methods)</term><term>Prevalence (MeSH)</term><term>Protein-Serine-Threonine Kinases (MeSH)</term><term>Recurrence (MeSH)</term><term>Retrospective Studies (MeSH)</term><term>Treatment Outcome (MeSH)</term><term>United States (epidemiology)</term><term>Veterans (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Anciens combattants (MeSH)</term><term>Femelle (MeSH)</term><term>Humains (MeSH)</term><term>Mâle (MeSH)</term><term>Positionnement du patient (méthodes)</term><term>Protein-Serine-Threonine Kinases (MeSH)</term><term>Protéines de Drosophila (MeSH)</term><term>Prévalence (MeSH)</term><term>Récidive (MeSH)</term><term>Résultat thérapeutique (MeSH)</term><term>Sujet âgé (MeSH)</term><term>Sujet âgé de 80 ans ou plus (MeSH)</term><term>Vertige positionnel paroxystique bénin (thérapie)</term><term>Vertige positionnel paroxystique bénin (épidémiologie)</term><term>États-Unis (épidémiologie)</term><term>Études de cohortes (MeSH)</term><term>Études rétrospectives (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Drosophila Proteins</term><term>Protein-Serine-Threonine Kinases</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Benign Paroxysmal Positional Vertigo</term><term>United States</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Patient Positioning</term></keywords><keywords scheme="MESH" qualifier="méthodes" xml:lang="fr"><term>Positionnement du patient</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Benign Paroxysmal Positional Vertigo</term></keywords><keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Vertige positionnel paroxystique bénin</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Vertige positionnel paroxystique bénin</term><term>États-Unis</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Cohort Studies</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Prevalence</term><term>Recurrence</term><term>Retrospective Studies</term><term>Treatment Outcome</term><term>Veterans</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Anciens combattants</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Protein-Serine-Threonine Kinases</term><term>Protéines de Drosophila</term><term>Prévalence</term><term>Récidive</term><term>Résultat thérapeutique</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Études de cohortes</term><term>Études rétrospectives</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>Background</b></p><p>The Mountain Home Veterans Affairs (VA) Medical Center has been diagnosing and treating veterans with benign paroxysmal positional vertigo (BPPV) for almost 2 decades. The clinic protocol includes a 2-week follow-up visit to determine the treatment outcome of the canalith repositioning treatment (CRT). To date, the characteristics of BPPV and treatment efficacy have not been reported in a cohort of veterans with BPPV.</p></div><div type="abstract" xml:lang="en"><p><b>Purpose</b></p><p>To determine the prevalence and characteristics of veterans diagnosed with BPPV in a Veterans Affairs Medical Center Audiology Clinic and to examine treatment outcomes.</p></div><div type="abstract" xml:lang="en"><p><b>Research Design</b></p><p>Retrospective chart review.</p></div><div type="abstract" xml:lang="en"><p><b>Study Sample</b></p><p>A total of 102 veterans who tested positive for BPPV in the Vestibular Clinic at the Mountain Home VA Medical Center from March 2010 to August 2011.</p></div><div type="abstract" xml:lang="en"><p><b>Results</b></p><p>In 102 veterans who were diagnosed with BPPV, the posterior semicircular canal was most often involved (75%), motion-provoked vertigo was the most common symptom (84%), and the majority (43%) were diagnosed with BPPV in their sixth decade. The prevalence of BPPV in the Audiology Vestibular Clinic was 15.6%. Forty-one percent of veterans reported a symptom onset within 12 months of treatment for BPPV; however, 36% reported their symptoms began > 36 months prior to treatment. CRT was effective (negative Dix-Hallpike/roll test) in most veterans (86%) following 1 treatment appointment (M = 1.6), but more than half reported incomplete symptom resolution (residual dizziness) at the follow-up appointment. Eighteen percent of veterans experienced a recurrence (M = 1.8 years; SD = 1.7 years).</p></div><div type="abstract" xml:lang="en"><p><b>Conclusions</b></p><p>The characteristics and treatment outcomes of BPPV in our veteran cohort was similar to what has been reported in the general population. Future work should focus on improving the timeliness of evaluation and treatment of BPPV and examining the time course and management of residual dizziness.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28973090</PMID><DateCompleted><Year>2018</Year><Month>09</Month><Day>11</Day></DateCompleted><DateRevised><Year>2018</Year><Month>09</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1558-9137</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>4</Issue><PubDate><Year>2017</Year><Month>Dec</Month><Day>12</Day></PubDate></JournalIssue><Title>American journal of audiology</Title><ISOAbbreviation>Am J Audiol</ISOAbbreviation></Journal><ArticleTitle>Characteristics and Treatment Outcomes of Benign Paroxysmal Positional Vertigo in a Cohort of Veterans.</ArticleTitle><Pagination><MedlinePgn>473-480</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1044/2017_AJA-16-0118</ELocationID><Abstract><AbstractText Label="Background" NlmCategory="UNASSIGNED">The Mountain Home Veterans Affairs (VA) Medical Center has been diagnosing and treating veterans with benign paroxysmal positional vertigo (BPPV) for almost 2 decades. The clinic protocol includes a 2-week follow-up visit to determine the treatment outcome of the canalith repositioning treatment (CRT). To date, the characteristics of BPPV and treatment efficacy have not been reported in a cohort of veterans with BPPV.</AbstractText><AbstractText Label="Purpose" NlmCategory="UNASSIGNED">To determine the prevalence and characteristics of veterans diagnosed with BPPV in a Veterans Affairs Medical Center Audiology Clinic and to examine treatment outcomes.</AbstractText><AbstractText Label="Research Design" NlmCategory="UNASSIGNED">Retrospective chart review.</AbstractText><AbstractText Label="Study Sample" NlmCategory="UNASSIGNED">A total of 102 veterans who tested positive for BPPV in the Vestibular Clinic at the Mountain Home VA Medical Center from March 2010 to August 2011.</AbstractText><AbstractText Label="Results" NlmCategory="UNASSIGNED">In 102 veterans who were diagnosed with BPPV, the posterior semicircular canal was most often involved (75%), motion-provoked vertigo was the most common symptom (84%), and the majority (43%) were diagnosed with BPPV in their sixth decade. The prevalence of BPPV in the Audiology Vestibular Clinic was 15.6%. Forty-one percent of veterans reported a symptom onset within 12 months of treatment for BPPV; however, 36% reported their symptoms began > 36 months prior to treatment. CRT was effective (negative Dix-Hallpike/roll test) in most veterans (86%) following 1 treatment appointment (M = 1.6), but more than half reported incomplete symptom resolution (residual dizziness) at the follow-up appointment. Eighteen percent of veterans experienced a recurrence (M = 1.8 years; SD = 1.7 years).</AbstractText><AbstractText Label="Conclusions" NlmCategory="UNASSIGNED">The characteristics and treatment outcomes of BPPV in our veteran cohort was similar to what has been reported in the general population. Future work should focus on improving the timeliness of evaluation and treatment of BPPV and examining the time course and management of residual dizziness.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Akin</LastName><ForeName>Faith W</ForeName><Initials>FW</Initials><AffiliationInfo><Affiliation>Vestibular Balance Laboratory and Auditory Vestibular Research Enhancement Award Program, James H. Quillen VA Veterans Affairs Medical Center, Mountain Home, TN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Audiology and Speech-Language Pathology, East Tennessee State University, Johnson City.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riska</LastName><ForeName>Kristal M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Vestibular Balance Laboratory and Auditory Vestibular Research Enhancement Award Program, James H. Quillen VA Veterans Affairs Medical Center, Mountain Home, TN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Audiology and Speech-Language Pathology, East Tennessee State University, Johnson City.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Audiology and Speech-Language Pathology, East Tennessee State University, Johnson City.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Audiology and Speech Pathology Service, San Diego VA Medical Center, La Jolla, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rouse</LastName><ForeName>Stephanie B</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>Vestibular Balance Laboratory and Auditory Vestibular Research Enhancement Award Program, James H. Quillen VA Veterans Affairs Medical Center, Mountain Home, TN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murnane</LastName><ForeName>Owen D</ForeName><Initials>OD</Initials><AffiliationInfo><Affiliation>Vestibular Balance Laboratory and Auditory Vestibular Research Enhancement Award Program, James H. Quillen VA Veterans Affairs Medical Center, Mountain Home, TN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Audiology and Speech-Language Pathology, East Tennessee State University, Johnson City.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Audiol</MedlineTA><NlmUniqueID>9114917</NlmUniqueID><ISSNLinking>1059-0889</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D029721">Drosophila Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="C000621134">ADUK protein, Drosophila</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D017346">Protein-Serine-Threonine Kinases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065635" MajorTopicYN="N">Benign Paroxysmal Positional Vertigo</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029721" MajorTopicYN="N">Drosophila Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056888" MajorTopicYN="N">Patient Positioning</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017346" MajorTopicYN="N">Protein-Serine-Threonine Kinases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014728" MajorTopicYN="Y">Veterans</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>12</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>04</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>9</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28973090</ArticleId><ArticleId IdType="pii">2654846</ArticleId><ArticleId IdType="doi">10.1044/2017_AJA-16-0118</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>Californie</li><li>Tennessee</li></region></list><tree><country name="États-Unis"><region name="Tennessee"><name sortKey="Akin, Faith W" sort="Akin, Faith W" uniqKey="Akin F" first="Faith W" last="Akin">Faith W. Akin</name></region><name sortKey="Murnane, Owen D" sort="Murnane, Owen D" uniqKey="Murnane O" first="Owen D" last="Murnane">Owen D. Murnane</name><name sortKey="Riska, Kristal M" sort="Riska, Kristal M" uniqKey="Riska K" first="Kristal M" last="Riska">Kristal M. Riska</name><name sortKey="Rouse, Stephanie B" sort="Rouse, Stephanie B" uniqKey="Rouse S" first="Stephanie B" last="Rouse">Stephanie B. Rouse</name><name sortKey="Williams, Laura" sort="Williams, Laura" uniqKey="Williams L" first="Laura" last="Williams">Laura Williams</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TestDixHallpikeV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000114 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000114 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= TestDixHallpikeV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:28973090
|texte= Characteristics and Treatment Outcomes of Benign Paroxysmal Positional Vertigo in a Cohort of Veterans.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:28973090" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a TestDixHallpikeV1
| This area was generated with Dilib version V0.6.37. |  |